74 lines
9.9 KiB
Ruby
74 lines
9.9 KiB
Ruby
class Cancerpredictfields
|
||
include Mongoid::Document
|
||
include Mongoid::Timestamps
|
||
include OrbitModel::Status
|
||
include OrbitModel::Impression
|
||
# encoding: utf-8
|
||
include OrbitTag::Taggable
|
||
include OrbitCategory::Categorizable
|
||
field :title ,type:String ,default:""
|
||
field :form_show , :type=> Hash ,default:{0=>{:variable=>"age",:name=>{"zh_tw"=>"年齡<br/>(age)","en"=>"age"},:is_num=>1, :hint=>{'zh_tw'=>'從 18 歲(含)開始至 93 歲','en'=>''} , :comment_text=>{'zh_tw'=>'年齡為該婦女於確診罹患乳癌時之年齡','en'=>''}, :choice_fields=> {"zh_tw"=>[],"en"=>[]},:range=>[18,93],:right=>0,:is_float=>0},
|
||
1=>{:variable=>"size",:name=>{"zh_tw"=>"腫瘤大小<br/>(tumor size)","en"=>"tumor size"},:is_num=>1,:hint=>{'zh_tw'=>'','en'=>''}, :comment_text=>{'zh_tw'=>'若有多個原發腫瘤，請輸入最大尺寸之原發腫瘤','en'=>''}, :choice_fields=> {"zh_tw"=>[],"en"=>[]},:range=>[1,300],:right=>0,:is_float=>0},
|
||
2=>{:variable=>"lymph_nodes_examined",:name=>{"zh_tw"=>"區域淋巴結檢查數目<br/>(Regional lymph nodes examined)","en"=>"Regional lymph nodes examined"},:is_num=>1,:hint=>{'zh_tw'=>'','en'=>''}, :comment_text=>{'zh_tw'=>'','en'=>''}, :choice_fields=> {"zh_tw"=>['未知'],"en"=>['unknown']},:range=>[0,90],:right=>0,:is_float=>0},
|
||
3=>{:variable=>"lymph_nodes_positive",:name=>{"zh_tw"=>"區域淋巴結侵犯數目<br/>(Regional lymph nodes positive)","en"=>"Regional lymph nodes positive"},:is_num=>1,:hint=>{'zh_tw'=>'','en'=>''}, :comment_text=>{'zh_tw'=>'此變項為預測重要變數，若無此資訊預測容易失真。','en'=>''}, :choice_fields=> {"zh_tw"=>['未知'],"en"=>['unknown']},:range=>[0,90],:right=>0,:is_float=>0},
|
||
4=>{:variable=>"grade",:name=>{"zh_tw"=>"腫瘤級數<br/>(tumor grade)","en"=>"tumor grade"},:is_num=>0,:hint=>{'zh_tw'=>'','en'=>''}, :comment_text=>{'zh_tw'=>'腫瘤級數代表腫瘤組織與正常組織間的分化程度，若無分化級數資訊，請選擇“未知”選項，將以級數 2 進行預測。','en'=>''}, :choice_fields=> {"zh_tw"=>['1','2','3','未知'],"en"=>['1','2','3','unknown']},:range=>[],:right=>0,:is_float=>0},
|
||
5=>{:variable=>"ER_status",:name=>{"zh_tw"=>"ER 狀態<br/>(ER status)","en"=>"ER status"},:is_num=>0,:hint=>{'zh_tw'=>'','en'=>''}, :comment_text=>{'zh_tw'=>'ER:雌激素受體，若無 ER 資訊請選擇未知，將以佔多數比例陽性作為後續預測。','en'=>''}, :choice_fields=> {"zh_tw"=>['陽性','陰性','未知'],"en"=>['positive','negative','unknown']},:range=>[],:right=>0,:is_float=>0},
|
||
6=>{:variable=>"PR_status",:name=>{"zh_tw"=>"PR 狀態<br/>(PR status)","en"=>"PR status"},:is_num=>0,:hint=>{'zh_tw'=>'','en'=>''}, :comment_text=>{'zh_tw'=>'PR:黃體素受體，若無 PR 資訊請選擇未知，將以佔多數比例陽性作為後續預測。','en'=>''}, :choice_fields=> {"zh_tw"=>['陽性','陰性','未知'],"en"=>['positive','negative','unknown']},:range=>[],:right=>1,:is_float=>0},
|
||
7=>{:variable=>"HER2_status",:name=>{"zh_tw"=>"HER2 狀態<br/>(HER2 status)，","en"=>"HER2 status"},:is_num=>0,:hint=>{'zh_tw'=>'','en'=>''}, :comment_text=>{'zh_tw'=>'HER2:第二型人類上皮成長因子接受器蛋白，若無 HER2 資訊請選擇未知，將以佔多數比例陰性作為後續預測。','en'=>''}, :choice_fields=> {"zh_tw"=>['陽性','陰性','未知'],"en"=>['positive','negative','unknown']},:range=>[],:right=>1,:is_float=>0},
|
||
8=>{:variable=>"Distant_Metastasis",:name=>{"zh_tw"=>"遠端轉移<br/>(DistantMetastasis)","en"=>"pathologic stage"},:is_num=>0,:hint=>{'zh_tw'=>'','en'=>''}, :comment_text=>{'zh_tw'=>'若無遠轉移資訊請選擇未知，將以佔多數比例未遠端轉移作為後續預測。','en'=>''}, :choice_fields=> {"zh_tw"=>['是','否','未知'],"en"=>['yes','no','unknown']},:range=>[],:right=>1,:is_float=>0},
|
||
9=>{:variable=>"micrometastasis",:name=>{"zh_tw"=>"顯微轉移<br/>(micrometastasis)","en"=>"pathologic stage"},:is_num=>0,:hint=>{'zh_tw'=>'','en'=>''}, :comment_text=>{'zh_tw'=>'若無顯微移資訊請選擇未知，將以無顯微轉移作為後續預測。','en'=>''}, :choice_fields=> {"zh_tw"=>['是','否','未知'],"en"=>['yes','no','unknown']},:range=>[],:right=>1,:is_float=>0},
|
||
10=>{:variable=>"tumor_direct_extension",:name=>{"zh_tw"=>"腫瘤浸潤至胸壁和/或皮膚<br/>(tumor direct extension to the chest wall and/or to the skin)","en"=>"tumor direct extension to the chest wall and/or to the skin"},:is_num=>0,:hint=>{'zh_tw'=>'','en'=>''}, :comment_text=>{'zh_tw'=>'若無腫瘤浸潤至胸壁或皮膚資訊請選擇未知，將以佔多數比例無腫瘤浸潤至胸壁作為後續預測。','en'=>''}, :choice_fields=> {"zh_tw"=>['是','否','未知'],"en"=>['yes','no','unknown']},:range=>[],:right=>1,:is_float=>0},
|
||
11=>{:variable=>"lvi",:name=>{"zh_tw"=>"淋巴管或血管侵犯<br/>(lymph vessel or vascular invasion, LVI)","en"=>"lymph vessel or vascular invasion, LVI"},:is_num=>0,:hint=>{'zh_tw'=>'','en'=>''}, :comment_text=>{'zh_tw'=>'若無淋巴管或血管侵犯資訊，請選擇“未知”選項，將以佔多數比例的淋巴管或血管未侵犯進行預測','en'=>''}, :choice_fields=> {"zh_tw"=>['是','否','未知'],"en"=>['yes','no','unknown']},:range=>[],:right=>1,:is_float=>0}
|
||
}
|
||
field :form_show_in_result , :type=> Hash ,default:{0=>{:variable=>"hormone_therapy",:name=>{"zh_tw"=>"賀爾蒙治療","en"=>"Hormone/steroid therapy"},:is_num=>0, :hint=>{'zh_tw'=>'適用賀爾蒙受體陽性病人','en'=>'Hormone (endocrine) therapy is available when ER-status is positive'} , :comment_text=>{'zh_tw'=>'','en'=>'<p>Hormone therapy, or endocrine therapy, involves a woman taking drugs to prevent the growth of tumour cells that are boosted by the hormone oestrogen. Drugs of this kind include tamoxifen (brand names include Nolvadex, Istabul, Valodex, and Soltamox) and aromatase inhibitors such as anastrozole, exemestane, and letrozole (brand names Arimidex, Aromasin, and Femara).</p>'+
|
||
'<p>Some hormone therapy drugs act by blocking the action of oestrogen on the cells and some work by lowering the amount of oestrogen in the body (NB hormone therapy for breast cancer is the opposite of hormone replacement therapy or HRT, which is taken by women to help INCREASE oestrogen levels to help deal with side-effects of the menopause).</p>'+
|
||
'<p>Treatments usually have the potential to cause harm as well as benefit. It is important to weigh up the risks of potential harm against the potential benefits of treatment in order to reach a decision. Some may cause more harm than benefit to some people.</p>'+
|
||
'<p>It is useful to switch between 1 and 5 years hormone therapy to compare the survival outcomes.</p>'}, :choice_fields=> {"zh_tw"=>['否','是'],"en"=>['No','Yes']},:range=>[]},
|
||
1=>{:variable=>"Chemotherapy",:name=>{"zh_tw"=>"化學治療","en"=>"Chemotherapy"},:is_num=>0,:hint=>{'zh_tw'=>'','en'=>''}, :comment_text=>{'zh_tw'=>'','en'=>''}, :choice_fields=> {"zh_tw"=>['否','是'],"en"=>['No','Yes']},:range=>[]},
|
||
2=>{:variable=>"Radiotherapy",:name=>{"zh_tw"=>"放射治療","en"=>"Radiotherapy"},:is_num=>0,:hint=>{'zh_tw'=>'','en'=>''}, :comment_text=>{'zh_tw'=>'','en'=>''}, :choice_fields=> {"zh_tw"=>['否','是'],"en"=>['No','Yes']},:range=>[]},
|
||
3=>{:variable=>"Targeted_therapy",:name=>{"zh_tw"=>"標靶治療","en"=>"Targeted therapy"},:is_num=>0,:hint=>{'zh_tw'=>'抗HER2治療','en'=>''}, :comment_text=>{'zh_tw'=>'','en'=>''}, :choice_fields=> {"zh_tw"=>['否','是'],"en"=>['No','Yes']},:range=>[]}
|
||
}
|
||
field :form_result_is_right , :type=> Integer ,default: 0
|
||
field :text_descibe ,type:Hash ,default:{"zh_tw"=>"歡迎使用台灣準備乳癌癒後系統！<br/>若要開始 請在下方輸入相關資訊","en"=>" Welcome to The after breast cancer healing system of Taiwanprepare!\nTo start, please enter the relevant information below."}
|
||
field :small ,type:Hash ,default:{'font_size'=>"0.825em",'active'=>0}
|
||
field :medium ,type:Hash ,default:{'font_size'=>"1em",'active'=>1}
|
||
field :large ,type:Hash ,default:{'font_size'=>"1.25em",'active'=>0}
|
||
field :head_images_id ,type:Array , default: [BSON::ObjectId('5df62cfc8cd8924e79000009'), BSON::ObjectId('5df745a58cd8924491000006'), BSON::ObjectId('5df745a58cd8924491000007'), BSON::ObjectId('5df745a58cd8924491000008'), BSON::ObjectId('5df745a58cd8924491000009')]
|
||
field :title_images_id ,type:Array , default: [BSON::ObjectId('5df87cd88cd8924491000036')]
|
||
field :title_texts ,type:String ,default:""
|
||
#field :image_uploader ,type:Object
|
||
scope :can_display, ->{where(:is_hidden=>false,:is_preview => false).any_of({:postdate.lt=>Time.now, :deadline.gt=>Time.now},{:postdate.lt=>Time.now, :deadline=>nil}).order_by([:is_top, :desc],[:postdate, :desc])}
|
||
scope :is_approved, ->{where(:approved => true)}
|
||
#before_create :set_expire
|
||
def update_user
|
||
User.find(update_user_id) rescue nil
|
||
end
|
||
def update_user=(user)
|
||
self.update_user_id = user.id
|
||
end
|
||
def email_members
|
||
MemberProfile.find(self.email_member_ids) rescue []
|
||
end
|
||
def email_addresses
|
||
addresses = self.email_members.collect{|member| member.email} rescue []
|
||
addresses = addresses +[self.other_mailaddress] if !self.other_mailaddress.blank?
|
||
addresses.flatten
|
||
end
|
||
def email
|
||
mail = Email.find(self.email_id) rescue nil
|
||
end
|
||
def expired?
|
||
(self.deadline < Time.now) rescue false
|
||
end
|
||
def destroy_email
|
||
mail = Email.find(self.email_id) rescue nil
|
||
mail.destroy if !mail.nil?
|
||
end
|
||
def self.remove_expired_status
|
||
self.where(:is_top => true, :top_end_date.ne => nil, :top_end_date.lt => Time.now).each do |b|
|
||
b.is_top = false
|
||
b.top_end_date = nil
|
||
b.save
|
||
end
|
||
end
|
||
end |